The Global CRISPR market is expected to witness a boost of 32.04% CAGR over the forecast period of 2019-2027

NEW YORK, Dec. 11, 2018 /PRNewswire/ -- KEY FINDINGS
The Global CRISPR market is expected to witness a boost of 32.04% CAGR over the forecast period of 2019-2027. Factors like increasing demand of the technology for drug discovery, late pregnancies leading to birth disorders and growing investments for path-breaking research technology are fueling the market growth.

Read the full report: https://www.reportlinker.com/p04461533


MARKET INSIGHTS
The global CRISPR market is segmented on the basis of products, applications, end-users.The product segment includes plasmids and vectors, design tools, Cas9 nuclease and gRNA, and delivery systems.

The application segment includes genetic engineering, genome editing, gRNA database/gene library, human stem cells, CRISPR plasmid, genetically modified organisms/crops and cell line engineering. The end-users for the CRISPR market include research foundation, academic institutes, pharma companies and biotech firms.

REGIONAL INSIGHTS
Regional segmentation of the market is done into Europe, Asia-Pacific, North America and rest of the world CRISPR markets.The Asia-Pacific market is expected to register the fastest growth over the forecast period.

The region is driven by high population growth in emerging nations of India and China and a growing prevalence of genetic diseases there. The North American market, on the other hand, is predicted to account for the highest revenue share by the end of the forecast period, with the U.S being its major contributor. The presence of leading market companies and growing consumer awareness related to this technology is responsible for propelling this region ahead.

COMPETITIVE INSIGHTS
Thermo Fisher Scientific, Editas Medicine, Crispr Therapeutics Ag, Sigma-Aldrich (Merck), Horizon Discovery Plc, Genscript, Lonza Group Ag, Sangamo Biosciences Inc,Integrated DNA Technologies (IDT), Origene Technologies Inc, New England Biolabs Inc, Transposagen Biopharmaceuticals Inc, Caribou Biosciences Inc, Precision Biosciences, Intellia Therapeutics Inc, Cellectis Bioresearch SAS and Novartis International Ag are few of the companies engaged in the global CRISPR market

Companies mentioned
1. ADDGENE
2. APPLIED STEMCELL, INC.
3. CARIBOU BIOSCIENCES INC.
4. CELLECTIS BIORESEARCH SAS
5. CRISPR THERAPEUTICS AG
6. DIACARTA, INC.
7. EDIGENE, INC.
8. EDITAS MEDICINE
9. GENECOPOEIA, INC.
10. GENEDATA AG
11. GENSCRIPT
12. HORIZON DISCOVERY PLC
13. INTEGRATED DNA TECHNOLOGIES
14. INTELLIA THERAPEUTICS INC.
15. LONZA GROUP AG
16. NEW ENGLAND BIOLABS INC.
17. NOVARTIS INTERNATIONAL AG
18. ORIGENE TECHNOLOGIES INC.
19. PRECISION BIOSCIENCES
20. SANGAMO THERAPEUTICS
21. SIGMA-ALDRICH (MERCK)
22. THERMO FISHER SCIENTIFIC
23. TRANSPOSAGEN BIOPHARMACEUTICALS INC.

Read the full report: https://www.reportlinker.com/p04461533

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker